544445 — Asston Pharmaceuticals Balance Sheet
0.000.00%
- IN₹748.24m
- IN₹820.81m
- IN₹250.39m
- 31
- 35
- 28
- 18
Annual balance sheet for Asston Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 0.325 | 13.7 | 1.24 | 0.064 | 1.99 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 47.1 | 62.1 | 90.7 | 169 | 261 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 59.9 | 80.5 | 107 | 183 | 270 |
| Net Property, Plant And Equipment | 9.24 | 8.78 | 11.3 | 10.9 | 9.56 |
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 69.2 | 89.3 | 137 | 203 | 281 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 45 | 54.5 | 97.9 | 121 | 150 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 67.9 | 80 | 117 | 139 | 174 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.29 | 9.31 | 19.9 | 63.9 | 107 |
| Total Liabilities & Shareholders' Equity | 69.2 | 89.3 | 137 | 203 | 281 |
| Total Common Shares Outstanding |